Webinar Date/Time: Thursday, September 28th, 2023 10:00 AM EDT
Attend this free, live webinar to learn how Biotalys has transformed their next-generation antibody-based R&D by implementing a fully integrated automation platform to support discovery, development, and bioprocessing of novel single-domain antibodies (sdAbs).
Register Free: https://www.biopharminternational.com/bp_w/data-platform-automation
Event Overview:
Discover how Biotalys uses a fully integrated workflow management and automation platform to increase efficiency and ensure data integrity during discovery and bioprocess development of single-domain antibodies (sdAbs).
The Genedata Biopharma platform acts as Biotalys’ fully integrated central data and workflow management system for all critical R&D information and allows them to connect activities across discovery, development, and bioprocessing.
By enabling instant information-sharing across projects and groups spanning high throughput screening, strain engineering (CLD), fermentation process (USP) development and analytics, and product purification (DSP), Genedata provides the key structured data foundation for decision-making and risk management.
This enables Biotays to develop and manufacture groundbreaking biological products faster and in a more economically viable manner.
Key Learning Objectives:
Learn how Biotalys uses Genedata to:
Who Should Attend:
Speaker:
Dominique Vlieghe, Ph.D
Data and Information Manager
Biotalys, Ghent, Belgium
Dr. Dominique Vlieghe has a Ph.D. in DNA Crystallography. Professionally, he has always operated in the interdisciplinary domain between science and IT, with a heavy focus on large biomolecule compounds. Through the years, his focus gradually shifted from (structural) Bioinformatics and Data Science to Scientific Data Management.
In his previous company, Ablynx, now part of Sanofi, he managed a team responsible for all scientific data management applications such as Electronic Lab Notebooks, LIMS, compound and reagent management systems, and data integration and analytics platforms. In 2019, he became the Data and Information Manager at Biotalys, where he focuses on the scientific data management landscape.
Register Free: https://www.biopharminternational.com/bp_w/data-platform-automation
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.